Studies of prevention, treatment and mechanisms of heart failure in the aging spontaneously hypertensive rat

Heart Failure Reviews

Volumn 7, Issue 1, 2002, Pages 71-88

  Bing, Oscar H L ^a   Conrad, Chester H ^a   Boluyt, Marvin O ^b   Robinson, Kathleen G ^a   Brooks, Wesley W ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Aging; Angiotensin II; Apoptosis; Energetics; Fibrosis; Heart failure; Heart failure prevention; Hypertrophy; Intracellular calcium; Microtubules; Myocardial function

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ARGININE; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; CAPTOPRIL; CARDIOVASCULAR AGENT; CARVEDILOL; COLCHICINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ENDOTHELIN 1; ISOPRENALINE; LISINOPRIL; LOSARTAN; NEUROHORMONE; TRANDOLAPRIL;

ADAPTATION SYNDROME; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; APOPTOSIS; BETA ADRENERGIC STIMULATION; CALCIUM CELL LEVEL; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MODEL; DOSE RESPONSE; DRUG MECHANISM; DRUG SELECTIVITY; EXTRACELLULAR MATRIX; GENETIC ASSOCIATION; HEART DISEASE; HEART FAILURE; HEART FUNCTION; HEART HYPERTROPHY; HEART MUSCLE; HORMONAL REGULATION; HYPERTENSION; LONG TERM CARE; MICROTUBULE; NONHUMAN; OXYGEN SUPPLY; PREVENTIVE MEDICINE; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SPONTANEOUSLY HYPERTENSIVE RAT;

AGING; ANIMALS; CARDIOMEGALY; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTENSION; MALE; MYOCARDIAL CONTRACTION; RATS; RATS, INBRED SHR;

EID: 0036173992     PISSN: 13824147     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1013753907135     Document Type: Review

References (102)

1. Epidemiology of heart failure
2. Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure Research
3. Cardiovascular regulatory mechanisms in advanced age
4. Histopathological types of cardiac fibrosis in myocardial disease
5. Muscle fiber orientation and connective tissue content in the hypertrophied human heart
6. Changes in nonmyocyte tissue composition associated with pressure overload of hypertrophic human hearts
7. Nonsynchronous changes in myocardial collagen mRNA and protein during aging: Effect of DOCA-salt hypertension
8. Age-dependent expression of fibrosis-related genes and collagen deposition in the rat myocardium
9. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system
10. Cardiac function and morphology with aging in the spontaneously hypertensive rat
11. The spontaneously hypertensive rat as a model of the transition from compensated left ventricular hypertrophy to failure
12. Development of a strain of spontaneously hypertensive rats
13. Similarities of genetic (spontaneous) hypertension. Man and rat
14. Renin in rats with spontaneous hypertension
15. Cardiac hypertrophy in spontaneously hypertensive rats
16. Impaired myocardial function in spontaneously hypertensive rats with heart failure
17. Chronic cardiac reactions. III. Factors involved in the development of structural dilatation
18. Effect of angiotensin-converting enzyme inhibition on myocardial fibrosis and function in hypertrophied and failing myocardium from the spontaneously hypertensive rat
19. The transition to failure in the spontaneously hypertensive rat
20. Myocyte remodeling during the progression to failure in rats with hypertension
21. Laser scanner measurement of central segment performance in isolated cardiac muscle preparations
22. Investigation of the mechanisms underlying the increased contraction of hypertrophied ventricular myocytes isolated from the spontaneously hypertensive rat
23. Contractile properties of ventricular myocytes isolated from spontaneously hypertensive rat
24. Contractile properties of left ventricular myocytes isolated from spontaneously hypertensive rats: Effect of angiotensin II
25. Cellular mechanisms of altered contractility in the hypertrophied heart: Big hearts, big sparks
26. Papillary muscle structure-function relations in the aging spontaneously hypertensive rat
27. Myocardial fibrosis and stiffness with hypertrophy and heart failure in the spontaneously hypertensive rat
28. Properties of ventricular myocytes isolated from the hypertrophied and failing hearts of spontaneously hypertensive rats
29. Cellular versus myocardial basis for the contractile dysfunction of hypertrophied myocardium
30. Intracellular calcium transients in myocardium from spontaneously hypertensive rats during the transition to heart failure
31. Hemodynamic determinants of the time-course of fall in canine left ventricular pressure
32. Relaxation and diastole of the heart
33. Cooperation within actin filament in vertebrate skeletal muscle
34. Effect of chronic colchicine administration on the myocardium of the aging spontaneously hypertensive rat
35. L-arginine does not prevent the transition to heart failure in the spontaneously hypertensive rat
36. Prevention of structural changes in the heart in hypertension by angiotensin converting enzyme inhibition
37. Alterations in cardiac gene expression during the transition from stable hypertrophy to heart failure. Marked upregulation of genes encoding extracellular matrix components
38. Altered inotropic responsiveness and gene expression of hypertrophied myocardium with captopril
39. Long-term treatment of spontaneously hypertensive rats with losartan and electrophysiological remodeling of cardiac myocytes
40. Regression of left ventricular hypertrophy and prevention of left ventricular dysfunction by captopril in the spontaneously hypertensive rat
41. Molecular basis of the regression of cardiac hypertrophy
42. Effects of subchronic treatment with trandolapril and enalapril on cardiovascular morphologic alterations in the aged spontaneously hypertensive rat with heart failure
43. Myocardial response to stress in cardiac hypertrophy and heart failure: Effect of antihypertensive drugs
44. Carvedilol prevents severe hypertensive cardiomyopathy and remodeling
45. MMP/TIMP expression in spontaneously hypertensive heart failure rats: The effect of ACE- and MMP-inhibition
46. Cardiac endothelin-1 plays a critical role in the functional deterioration of left ventricles during the transition from compensatory hypertrophy to congestive heart failure in salt-sensitive hypertensive rats
47. Lessons from rat models of hypertension: From Goldblatt to genetic engineering
48. Resting and active mechanical properties of trabeculae carneae from aged male rats
49. Myocardial fibrosis: Role of angiotensin II and aldosterone
50. Matrix gene expression and decompensated heart failure: The aged SHR model
51. Myocardial osteopontin expression coincides with the development of heart failure
52. Temporal regulation of extracellular matrix components in transition from compensatory hypertrophy to decompensatory heart failure
53. Localization of alpha1(I) collagen mRNA in myocardium from the spontaneously hypertensive rat during the transition from compensated hypertrophy to failure
54. Advanced hypertensive heart disease in spontaneously hypertensive rats. Lisinopril-mediated regression of myocardial fibrosis
55. Changes in collagen phenotypes during progression and regression of cardiac hypertrophy
56. Myocardial stiffness is attributed to alterations in cross-linked collagen rather than total collagen or phenotypes in spontaneously hypertensive rats
57. Effects of reperfusion after coronary artery occlusion on post- infarction scar tissue
58. Appearance and regression of rat pouch tissue
59. Captopril modifies gene expression in hypertrophied and failing hearts of aged spontaneously hypertensive rats
60. Soluble transforming growth factor-beta type II receptor inhibits negative remodeling, fibroblast transdifferentiation, and intimal lesion formation but not endothelial growth
61. The cellular basis of dilated cardiomyopathy in humans
62. Hypothesis: Apoptosis may be a mechanism for the transition to heart failure with chronic pressure overload
63. Apoptosis in hypertensive heart disease
64. Increased cardiomyocyte apoptosis during the transition to heart failure in the spontaneously hypertensive rat
65. Contribution of non-cardiomyocyte apoptosis to cardiac remodelling that occurs in the transition from compensated hypertrophy to heart failure in spontaneously hypertensive rats
66. Angiotensin II induces apoptosis of adult ventricular myocytes in vitro
67. Mechanical properties of myocardium from hypertrophied rat hearts. A comparison between hypertrophy induced by senescence and by aortic banding
68. Cellular and molecular aspects of contractile dysfunction in heart failure
69. 2+ handling and vulnerability to ventricular fibrillation in spontaneously hypertensive rats
70. Effects of treppe and calcium on intra-cellular calcium and function in the failing heart from the spontaneously hypertensive rat
71. Alterations in intracellular calcium handling associated with the inverse force-frequency relation in human dilated cardiomyopathy
72. G proteins in heart disease
73. Role of altered G-protein expression in the regulation of myocardial adenylate cyclase activity and force of contraction in spontaneous hypertensive cardiomyopathy in rats
74. Modulation of left and right ventricular beta-adrenergic receptors from spontaneously hypertensive rats with left ventricular hypertrophy and failure
75. Differential effects of cardiac hypertrophy and failure on right versus left ventricular calcium activation
76. Morphometry of human coronary capillaries during normal growth and the effect of age in left ventricular pressure-overload hypertrophy
77. Coronary vascular changes in the progression and regression of hypertensive heart disease
78. Morphometric analysis of cardiac hypertrophy during development, maturation, and senescence in spontaneously hypertensive rats
79. Functional and metabolic properties in hearts from aged spontaneously hypertensive rats
80. Alterations of energy metabolism in the spontaneously hypertensive rat: A 31P nuclear magnetic resonance study
81. Differences in ischaemia tolerance between hypertrophied hearts of adult and aged spontaneously hypertensive rats
82. Intracellular high-energy phosphate transfer in normal and hypertrophied myocardium
83. 31P-NMR analysis of congestive heart failure in the SHHF/Mcc-facp rat heart
84. Oxygen cost of stress development in hypertrophied and failing hearts from the spontaneously hypertensive rat
85. Myocardial oxygen consumption during experimental hypertrophy and congestive heart failure
86. Mechanisms for the abnormal energetics of pressure-induced hypertrophy of cat myocardium
87. Increased myothermal economy of isometric force generation in compensated cardiac hypertrophy induced by pulmonary artery constriction in the rabbit. A characterization of heat liberation in normal and hypertrophied right ventricular papillary muscles
88. The economy of isometric force development, myosin isoenzyme pattern and myofibrillar ATPase activity in normal and hypothyroid rat myocardium
89. Myosin isoenzyme changes in several models of rat cardiac hypertrophy
90. The hibernating myocardium
91. Tolerance to hypoxia of myocardium from adult and aged spontaneously hypertensive rats
92. Cardiac muscle function during and after hypoxia: Effects of glucose concentration, mannitol and isoproternol
93. The "stone heart": A challenge to the biochemist
94. Cytoskeletal role in the contractile dysfunction of hypertrophied myocardium
95. Role of microtubules in contractile dysfunction of hypertrophied cardiocytes
96. Direct effects of colchicine on myocardial function: Studies in hypertrophied and failing spontaneously hypertensive rats
97. Role of microtubules in the transition from compensated cardiac hypertrophy to failure
98. Enhanced galactosyltransferase expression in the failing hearts of spontaneously hypertensive rats
99. Endogenous retroviral transcripts in myocytes from spontaneously hypertensive rats
100. Hypothesis: Link between endogenous retroviruses and cardiovascular disease
101. Myocardial mechanics in the spontaneously hypertensive rat